Epidemiology, Risk Factors, and Management of Biphasic Anaphylaxis

被引:0
作者
Giannetti, Matthew P. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 60 Fenwood Rd,Hale Bldg Transformat Med,5 Floor, Boston, MA 02132 USA
[2] Harvard Med Sch, Boston, MA 02132 USA
关键词
Anaphylaxis; Biphasic anaphylaxis; Tryptase; Mast cell; EMERGENCY-DEPARTMENT PATIENTS; PRACTICE PARAMETER UPDATE; NATIONAL INSTITUTE; RECOGNITION; EPINEPHRINE; SEVERITY; CHILDREN; ALLERGY;
D O I
10.1007/s11882-024-01179-1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of ReviewBiphasic anaphylaxis is a variant of anaphylaxis characterized by recurrence of symptoms after initial resolution of anaphylaxis. It was first described in the mid 1990s by Popa and Lerner. Our understanding of the pathophysiology and epidemiology of the condition has advanced considerably since then. The purpose of this manuscript is to review the literature surrounding biphasic anaphylaxis while highlighting key works and recent advances.Recent FindingsPrior studies have estimated biphasic anaphylaxis occurs in 0.4-20% of anaphylaxis episodes. The wide range may be related to differences in anaphylaxis diagnostic criteria which was inconsistent across studies. Recently identified risk factors for occurrence of biphasic anaphylaxis include severe initial symptoms including hypotension or hypoxia, delay in epinephrine use, and greater than one dose of epinephrine required to treat symptoms.SummaryDespite our progress to better understand biphasic anaphylaxis, there remain gaps in the literature. This article aims to review the recent literature including, epidemiology, risk factors, and management of biphasic anaphylaxis.
引用
收藏
页码:651 / 656
页数:6
相关论文
共 50 条
  • [41] Risk factors and treatment of refractory anaphylaxis - a review of case reports
    Francuzik, Wojciech
    Doelle, Sabine
    Worm, Margitta
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (04) : 307 - 314
  • [42] Anaphylaxis: epidemiology, aetiology and relevance for the clinic
    Dhami, Sangeeta
    Sheikh, Aziz
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (09) : 889 - 895
  • [43] Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors
    De Schryver, Sarah
    Halbrich, Michelle
    Clarke, Ann
    La Vieille, Sebastien
    Eisman, Harley
    Alizadehfar, Reza
    Joseph, Lawrence
    Morris, Judy
    Ben-Shoshan, Moshe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (04) : 1138 - 1142
  • [44] Risk Factors in Severe Anaphylaxis: Which Matters the Most, Food or Cofactors
    Casas-Saucedo, R.
    de la Cruz, C.
    Araujo-Sanchez, G.
    Gelis, S.
    Jimenez, T.
    Riggioni, S.
    San Bartolome, C.
    Pascal, M.
    Bartra Tomas, J.
    Munoz-Cano, R.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022, 32 (04) : 282 - 290
  • [45] Risk Factors for Refractory Anaphylaxis in the Emergency Department
    Yazici, Ramiz
    Mutlu, Huseyin
    Sert, Ekrem Taha
    Kokulu, Kamil
    Turan, Omer Faruk
    EMERGENCY MEDICINE INTERNATIONAL, 2024, 2024
  • [46] Fatal Anaphylaxis: Mortality Rate and Risk Factors
    Turner, Paul J.
    Jerschow, Elina
    Umasunthar, Thisanayagam
    Lin, Robert
    Campbell, Dianne E.
    Boyle, Robert J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (05) : 1169 - 1179
  • [47] Epidemiology, risk factors and management of paediatric diabetic retinopathy
    Sultan, Marla B.
    Starita, Carla
    Huang, Kui
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (03) : 312 - 317
  • [48] Biphasic anaphylaxis to gemifloxacin
    Yilmaz, Insu
    Dogan, Serkan
    Tutar, Nuri
    Kanbay, Asiye
    Buyukoglan, Hakan
    Demir, Ramazan
    ASIA PACIFIC ALLERGY, 2012, 2 (04) : 280 - 282
  • [49] Recognition and Management of Food-Induced Anaphylaxis
    Keet, Corinne
    PEDIATRIC CLINICS OF NORTH AMERICA, 2011, 58 (02) : 377 - +
  • [50] Anaphylaxis: risk factors for recurrence
    Mullins, RJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (08) : 1033 - 1040